Status Epilepticus in Children
Introduction to Status Epilepticus in Children
Status epilepticus (SE) is a neurological emergency that requires prompt recognition and treatment to prevent significant morbidity and mortality. In children, it presents unique challenges due to age-specific etiologies, pharmacokinetics, and long-term developmental concerns. This comprehensive guide aims to provide medical professionals with up-to-date information on the definition, etiology, clinical presentation, diagnosis, and management of status epilepticus in the pediatric population.
Definition of Status Epilepticus
The International League Against Epilepsy (ILAE) defines status epilepticus as:
- Operational definition (t1): A seizure lasting >5 minutes or recurrent seizures without recovery of consciousness between episodes.
- Time point (t2) of ongoing seizure activity: After 30 minutes, long-term consequences may occur.
Status epilepticus is further classified into:
- Convulsive Status Epilepticus (CSE): Involves tonic, clonic, or tonic-clonic movements.
- Non-Convulsive Status Epilepticus (NCSE): Altered mental status without prominent motor symptoms.
Etiology of Status Epilepticus in Children
The causes of status epilepticus in children vary by age and can be categorized as follows:
Neonates (0-1 month):
- Hypoxic-ischemic encephalopathy
- Intracranial hemorrhage
- Metabolic disturbances (hypoglycemia, electrolyte imbalances)
- Infections (meningitis, encephalitis)
- Inborn errors of metabolism
Infants and Young Children (1 month - 2 years):
- Febrile status epilepticus
- Central nervous system infections
- Developmental brain abnormalities
- Trauma
- Toxic ingestions
Older Children and Adolescents (>2 years):
- Antiepileptic drug non-compliance or withdrawal
- Intractable epilepsy
- Trauma
- Tumors
- Autoimmune encephalitis
Clinical Presentation of Status Epilepticus
The clinical presentation of status epilepticus can vary depending on the type and underlying etiology:
Convulsive Status Epilepticus:
- Prolonged tonic, clonic, or tonic-clonic movements
- Altered consciousness
- Autonomic dysfunction (tachycardia, hypertension, hyperthermia)
- Respiratory compromise
Non-Convulsive Status Epilepticus:
- Altered mental status or coma
- Subtle motor symptoms (eye deviation, nystagmus, facial twitching)
- Autonomic changes (tachycardia, fluctuations in blood pressure)
As status epilepticus progresses, patients may develop:
- Respiratory failure
- Hypotension
- Hyperthermia
- Metabolic acidosis
- Rhabdomyolysis
Diagnosis of Status Epilepticus
Diagnosis of status epilepticus is primarily clinical but should be supported by the following investigations:
Immediate Investigations:
- Blood glucose
- Electrolytes (sodium, potassium, calcium, magnesium)
- Complete blood count
- Blood gas analysis
- Antiepileptic drug levels (if applicable)
- Toxicology screen
Neuroimaging:
- CT scan: To rule out acute intracranial pathology
- MRI: For detailed evaluation of brain structure (when patient is stable)
Electroencephalography (EEG):
- Continuous EEG monitoring is crucial, especially in:
- Refractory status epilepticus
- Suspected non-convulsive status epilepticus
- Patients not regaining consciousness after apparent seizure cessation
Additional Tests (as indicated):
- Lumbar puncture: If CNS infection is suspected
- Metabolic and genetic studies: In cases of recurrent status epilepticus or suspected inborn errors of metabolism
Management of Status Epilepticus in Children
Management of status epilepticus follows a time-sensitive, stepwise approach:
0-5 minutes: Stabilization
- Assess and secure airway, breathing, and circulation (ABC)
- Provide oxygen
- Establish intravenous access
- Check blood glucose and treat hypoglycemia if present
- Rapid neurological examination
5-20 minutes: First-line Treatment
- Benzodiazepines:
- Midazolam: 0.2 mg/kg IM/IN (max 10 mg) or 0.1 mg/kg IV (max 4 mg)
- Lorazepam: 0.1 mg/kg IV (max 4 mg)
- Diazepam: 0.3 mg/kg IV (max 10 mg) or 0.5 mg/kg PR (max 20 mg)
- Repeat benzodiazepine dose once if seizures continue after 5 minutes
20-40 minutes: Second-line Treatment
- Fosphenytoin: 20 mg PE/kg IV (max 1500 mg)
- Phenobarbital: 20 mg/kg IV
- Valproic acid: 40 mg/kg IV (contraindicated in suspected metabolic disorders)
- Levetiracetam: 60 mg/kg IV (max 4500 mg)
40-60 minutes: Third-line Treatment
- Continuous infusion of one of the following:
- Midazolam: 0.2 mg/kg bolus, then 0.1-2 mg/kg/hour
- Pentobarbital: 5-15 mg/kg bolus, then 0.5-5 mg/kg/hour
- Propofol: 1-2 mg/kg bolus, then 2-10 mg/kg/hour (caution: risk of propofol infusion syndrome)
Refractory Status Epilepticus (>60 minutes)
- Continue third-line treatment
- Consider alternative therapies:
- Ketamine
- Topiramate
- Lacosamide
- Pyridoxine (in young infants)
- Initiate EEG monitoring if not already done
- Consider immunotherapy if autoimmune etiology is suspected
Supportive Care
- Manage hyperthermia
- Correct electrolyte imbalances
- Maintain normoglycemia
- Treat increased intracranial pressure if present
- Monitor for and manage complications
Complications of Status Epilepticus
Status epilepticus can lead to various complications, including:
- Respiratory failure and hypoxia
- Cardiovascular instability
- Cerebral edema and increased intracranial pressure
- Metabolic acidosis
- Hyperthermia
- Rhabdomyolysis and acute kidney injury
- Neuronal injury and long-term cognitive impairment
- Developmental delays in young children
- Drug-related adverse effects (e.g., respiratory depression from benzodiazepines)
Prognosis of Status Epilepticus in Children
The prognosis of status epilepticus in children depends on several factors:
- Underlying etiology
- Age of the child
- Duration of status epilepticus
- Promptness and adequacy of treatment
- Presence of complications
Generally:
- Mortality rates are lower in children compared to adults (1-3% vs 10-20%)
- Febrile status epilepticus generally has a good prognosis
- Symptomatic etiologies (e.g., CNS infections, tumors) have worse outcomes
- Refractory status epilepticus is associated with higher morbidity and mortality
- Long-term sequelae may include:
- Cognitive impairment
- Development of epilepsy
- Motor deficits
- Behavioral problems
Regular follow-up and neuropsychological assessment are crucial for children who have experienced status epilepticus, especially in cases of prolonged or recurrent episodes.
Status Epilepticus in Children
- Question: What is the definition of status epilepticus according to the International League Against Epilepsy (ILAE)? Answer: A seizure lasting longer than 5 minutes or recurrent seizures without recovery of consciousness between episodes
- Question: What is the most common type of status epilepticus in children? Answer: Convulsive status epilepticus
- Question: Which age group has the highest incidence of status epilepticus? Answer: Children under 1 year of age
- Question: What is the most common etiology of status epilepticus in children? Answer: Febrile status epilepticus
- Question: Which medication is typically the first-line treatment for status epilepticus in the prehospital setting? Answer: Benzodiazepines (e.g., midazolam, diazepam, or lorazepam)
- Question: What is the recommended first-line benzodiazepine for prehospital treatment of status epilepticus in children? Answer: Intramuscular (IM) midazolam
- Question: What is the time frame typically used to define refractory status epilepticus? Answer: Seizures persisting despite two appropriately dosed anti-seizure medications
- Question: Which is the preferred route of administration for benzodiazepines in the hospital setting for status epilepticus? Answer: Intravenous (IV)
- Question: What is the recommended second-line treatment for status epilepticus if benzodiazepines fail? Answer: Fosphenytoin, valproic acid, or levetiracetam
- Question: Which complication of status epilepticus is associated with hyperthermia, rhabdomyolysis, and multi-organ failure? Answer: Status epilepticus-induced neurological emergency (SINE)
- Question: What is the primary goal of treatment in status epilepticus? Answer: Rapid termination of seizure activity to prevent neuronal injury
- Question: Which imaging modality is typically recommended in new-onset status epilepticus without a clear etiology? Answer: Brain MRI
- Question: What is the most common electrolyte abnormality associated with prolonged status epilepticus? Answer: Hyponatremia
- Question: Which medication is often used as a third-line agent for refractory status epilepticus? Answer: Phenobarbital
- Question: What is the term for status epilepticus that continues or recurs despite 24 hours of anesthetic treatment? Answer: Super-refractory status epilepticus
- Question: Which continuous EEG pattern is characteristic of non-convulsive status epilepticus? Answer: Continuous spike-and-wave discharges
- Question: What is the recommended duration of continuous EEG monitoring in children with refractory status epilepticus? Answer: At least 24 hours after seizure control is achieved
- Question: Which antiepileptic drug is contraindicated in children with mitochondrial disorders presenting with status epilepticus? Answer: Valproic acid
- Question: What is the most common infectious cause of status epilepticus in children? Answer: Viral encephalitis (particularly herpes simplex virus)
- Question: Which vitamin deficiency can present with status epilepticus, particularly in infants? Answer: Pyridoxine (Vitamin B6) deficiency
- Question: What is the recommended dose of lorazepam for the initial treatment of status epilepticus in children? Answer: 0.1 mg/kg IV (maximum 4 mg per dose)
- Question: Which medication is often used for induction of anesthesia in refractory status epilepticus? Answer: Propofol or midazolam continuous infusion
- Question: What is the target range for therapeutic hypothermia, if used in super-refractory status epilepticus? Answer: 32-34°C (89.6-93.2°F)
- Question: Which neurological complication is associated with long-term cognitive deficits following status epilepticus? Answer: Hippocampal sclerosis
- Question: What is the mortality rate associated with status epilepticus in children? Answer: Approximately 3-5%
- Question: Which autoimmune condition should be considered in new-onset refractory status epilepticus without clear etiology? Answer: Anti-NMDA receptor encephalitis
- Question: What is the recommended duration of weaning from anesthetic agents in refractory status epilepticus? Answer: Gradual weaning over 12-24 hours
- Question: Which metabolic disorder can present with status epilepticus and is treated with a ketogenic diet? Answer: GLUT1 deficiency syndrome
- Question: What is the role of pyridoxal 5'-phosphate in the management of status epilepticus? Answer: It is used as a therapeutic trial in suspected pyridoxine-dependent epilepsy
- Question: Which anti-epileptic drug has shown efficacy in treating FIRES (Febrile Infection-Related Epilepsy Syndrome)? Answer: Anakinra (IL-1 receptor antagonist)
Disclaimer
The notes provided on Pediatime are generated from online resources and AI sources and have been carefully checked for accuracy. However, these notes are not intended to replace standard textbooks. They are designed to serve as a quick review and revision tool for medical students and professionals, and to aid in theory exam preparation. For comprehensive learning, please refer to recommended textbooks and guidelines.
